November 18, 2026 |
New research from Inizio Evoke explores the growing complexity of oncology innovation and how pharmaceutical companies can better support healthcare professionals (HCPs).

The pace of oncology innovation is transforming cancer care. From breakthrough therapies to advances in precision medicine, scientific progress is creating new opportunities for patients. Yet translating these advances into clinical practice is becoming increasingly complex.
A new white paper, authored by Maria Dzialo, PhD, Associate Director, Medical Strategy, Inizio Evoke, Chasing the Fourth Wave: The human cost of keeping pace, explores the hidden pressures facing oncologists, drawing on research conducted across six countries.
Read the white paper here.
This content was provided by Inizio